Treatment of Posttraumatic Swelling and Pain With Zhi Kang Capsule

• Status: Unknown status
• Trial end date: 2018-03-13
• Target enrollment: 0
• Participant gender: All

Summary

Zhi Kang Capsule functions for hemostasis and detumescence and can be used for traumatic bleeding, uterine bleeding, hematemesis and hematochezia.This randomized controlled trial was conducted to confirm the efficacy and safety of Zhi Kang Capsule in the treatment of posttraumatic swelling and pain,and also in a wide range of applications by open clinical observation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Peking University People's Hospital

Criteria

Inclusion Criteria:

• diagnosis of limb closed acute fracture, fracture occurred within 14 days, need for surgical treatment;

• age ranged from 18 to 80 years old, both male and female;

• voluntarily signed the informed consent form as the subjects.

Exclusion Criteria:

• open fracture

• multiple fractures (more than 1) or with vascular, nerve and visceral injuries

• severe primary diseases associated with heart, brain, liver, kidney, lung and hematopoietic system

• allergic constitution, mental patients

• patients with severe gastrointestinal diseases, such as ulcers; patients with severe metabolic diseases

• patients with history of alcohol addiction or drug abuse

• patients with poor compliance

• lactating women, women of pregnancy or childbearing age or male patients, do not agree to adopt effective contraceptive measures during the study period

• participants who participated in other clinical trials within the first three months of the study